Repligen
RGEN
#1868
Rank
NZ$19.67 B
Marketcap
NZ$309.84
Share price
6.13%
Change (1 day)
19.16%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): NZ$0.12 Billion

According to Repligen 's latest financial reports the company's current earnings are NZ$0.78 Billion. In 2025 the company made an earning of NZ$0.14 Billion, an increase over its 2024 earnings that were of -NZ$11.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.12 B-13.68%
2025 NZ$0.14 B-1430.84%
2024 -NZ$11.24 Million-113.01%
2023 NZ$86.33 M-78.01%
2022 NZ$0.39 B33.37%
2021 NZ$0.29 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$63.15 M25.93%
2018 NZ$50.15 M105.61%
2017 NZ$24.39 M-11.46%
2016 NZ$27.54 M14.91%
2015 NZ$23.97 M20.26%
2014 NZ$19.93 M-51.49%
2013 NZ$41.09 M90.98%
2012 NZ$21.51 M
2010 NZ$0.31 M-103.81%
2009 -NZ$8.18 Million-223.84%
2008 NZ$6.6 M
2006 -NZ$4.44 Million229.64%
2005 -NZ$1.35 Million-89.16%
2004 -NZ$12.42 Million-16.86%
2003 -NZ$14.93 Million88.72%
2002 -NZ$7.92 Million-27.88%
2001 -NZ$10.97 Million-1.74%
2000 -NZ$11.17 Million85.93%
1999 -NZ$6.01 Million159.16%
1998 -NZ$2.32 Million85.71%
1997 -NZ$1.25 Million-70.83%
1996 -NZ$4.28 Million-72.41%
1995 -NZ$15.51 Million-60.63%
1994 -NZ$39.38 Million45.39%
1993 -NZ$27.09 Million39.45%
1992 -NZ$19.43 Million-32.3%
1991 -NZ$28.69 Million6.62%
1990 -NZ$26.91 Million1577.78%
1989 -NZ$1.61 Million-57.14%
1988 -NZ$3.75 Million-362.5%
1987 NZ$1.42 M-130.77%
1986 -NZ$4.64 Million136.36%
1985 -NZ$1.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.30 B 9,196.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$13.60 B 10,178.60%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$20.40 B 15,310.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.22 B 15,929.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.2 Billion-248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.4 Billion-400.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.45 B 1,001.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.44 B 236.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.33 Billion-347.20%๐Ÿ‡บ๐Ÿ‡ธ USA